TY - JOUR
T1 - Current review of the SarQoL®
T2 - a health-related quality of life questionnaire specific to sarcopenia
AU - Beaudart, Charlotte
AU - Reginster, Jean Yves
AU - Geerinck, Anton
AU - Locquet, Médéa
AU - Bruyère, Olivier
N1 - Publisher Copyright:
© 2017 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2017/7/4
Y1 - 2017/7/4
N2 - Introduction: Sarcopenia, defined by a progressive and generalized loss of muscle mass and muscle function, is associated with many harmful clinical consequences. Several studies have reported the impact of sarcopenia on health-related quality of life (HRQoL) using generic quality of life (QoL) questionnaires. The results of these observational studies are quite heterogenous. Indeed, generic tools may not be able to detect subtle effects of sarcopenia on QoL. Recently, a sarcopenia-specific HRQoL questionnaire was developed and validated in a population of sarcopenic subjects to more accurately assess the impact of sarcopenia on QoL. Areas covered: The purpose of this review is to present evidence regarding the impact of sarcopenia on QoL and to introduce a new specific HRQoL questionnaire, the SarQoL®. Expert commentary: The self-administered SarQoL®, initially developed in French, comprises 55 items translated into 22 questions. The questionnaire has been shown to be understandable, valid, consistent, and reliable and can therefore be recommended for clinical and research purposes. The questionnaire is now available in 11 different languages with another 20 translations in progress. The instrument’s sensitivity to change still needs to be assessed in future longitudinal studies.
AB - Introduction: Sarcopenia, defined by a progressive and generalized loss of muscle mass and muscle function, is associated with many harmful clinical consequences. Several studies have reported the impact of sarcopenia on health-related quality of life (HRQoL) using generic quality of life (QoL) questionnaires. The results of these observational studies are quite heterogenous. Indeed, generic tools may not be able to detect subtle effects of sarcopenia on QoL. Recently, a sarcopenia-specific HRQoL questionnaire was developed and validated in a population of sarcopenic subjects to more accurately assess the impact of sarcopenia on QoL. Areas covered: The purpose of this review is to present evidence regarding the impact of sarcopenia on QoL and to introduce a new specific HRQoL questionnaire, the SarQoL®. Expert commentary: The self-administered SarQoL®, initially developed in French, comprises 55 items translated into 22 questions. The questionnaire has been shown to be understandable, valid, consistent, and reliable and can therefore be recommended for clinical and research purposes. The questionnaire is now available in 11 different languages with another 20 translations in progress. The instrument’s sensitivity to change still needs to be assessed in future longitudinal studies.
KW - muscle function
KW - Muscle impairments
KW - quality of life assessment
KW - sarcopenia
KW - specific questionnaire
UR - http://www.scopus.com/inward/record.url?scp=85027356346&partnerID=8YFLogxK
U2 - 10.1080/14737167.2017.1360768
DO - 10.1080/14737167.2017.1360768
M3 - Review article
C2 - 28749192
AN - SCOPUS:85027356346
SN - 1473-7167
VL - 17
SP - 335
EP - 341
JO - Expert Review of Pharmacoeconomics & Outcomes Research
JF - Expert Review of Pharmacoeconomics & Outcomes Research
IS - 4
ER -